Literature DB >> 8810348

The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner.

C Yan1, A Z Zhao, J K Bentley, J A Beavo.   

Abstract

We report here the identification of cDNAs for three new mouse PDE1C splice variants and the characterization of their kinetics, regulation by Ca2+, sensitivities to inhibitors, and tissue/cellular expression patterns. Sequence analysis indicated that these three cDNAs (PDE1C1, PDE1C4, and PDE1C5), together with our previously reported PDE1C2 and PDE1C3, are alternative splice products of the PDE1C gene. The results from RNase protection analysis and in situ hybridization indicated that the expression of the different PDE1C splice variants is differentially regulated in a tissue/cell-specific manner. Particularly, high levels of PDE1C mRNAs were found in the olfactory epithelium, testis, and several regions of mouse brain such as cerebellar granule cells. All of these splice variants have similar kinetic properties, showing high affinities and approximately the same relative Vmax values for both cAMP and cGMP. However, they responded to Ca2+ stimulation differently. In addition, they show different sensitivities to the calmodulin-dependent phosphodiesterase inhibitors, KS505a and SCH51866. Substrate competition experiments suggested the presence of only one catalytic site on these PDE1C isozymes for both cAMP and cGMP. In summary, these findings suggest that the PDE1C gene undergoes tissue-specific alternative splicing that generates structurally and functionally diverse gene products.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810348     DOI: 10.1074/jbc.271.41.25699

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  A cGMP-signaling pathway in a subset of olfactory sensory neurons.

Authors:  M R Meyer; A Angele; E Kremmer; U B Kaupp; F Muller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 2.  Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.

Authors:  Thérèse Keravis; Claire Lugnier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  An update on vinpocetine: New discoveries and clinical implications.

Authors:  Yi-Shuai Zhang; Jian-Dong Li; Chen Yan
Journal:  Eur J Pharmacol       Date:  2017-11-26       Impact factor: 4.432

4.  Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.

Authors:  Toru Hashimoto; Grace E Kim; Richard S Tunin; Tolulope Adesiyun; Steven Hsu; Ryo Nakagawa; Guangshuo Zhu; Jennifer J O'Brien; Joseph P Hendrick; Robert E Davis; Wei Yao; David Beard; Helen R Hoxie; Lawrence P Wennogle; Dong I Lee; David A Kass
Journal:  Circulation       Date:  2018-10-30       Impact factor: 29.690

5.  Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.

Authors:  Claire Y Zhao; Joseph L Greenstein; Raimond L Winslow
Journal:  J Mol Cell Cardiol       Date:  2015-09-23       Impact factor: 5.000

6.  Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.

Authors:  S D Rybalkin; K E Bornfeldt; W K Sonnenburg; I G Rybalkina; K S Kwak; K Hanson; E G Krebs; J A Beavo
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

7.  Evolution of multiple phosphodiesterase isoforms in stickleback involved in cAMP signal transduction pathway.

Authors:  Yukuto Sato; Yasuyuki Hashiguchi; Mutsumi Nishida
Journal:  BMC Syst Biol       Date:  2009-02-20

Review 8.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 9.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

10.  Phosphodiesterase 1C is dispensable for rapid response termination of olfactory sensory neurons.

Authors:  Katherine D Cygnar; Haiqing Zhao
Journal:  Nat Neurosci       Date:  2009-03-22       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.